Bath & Body Works Stock Plummets to New 52-Week Low at $24.93

Bath & Body Works, Inc. has reached a new 52-week low, trading at USD 24.93 as of September 19, 2025. This marks a significant decline for the small-cap company, which operates within the footwear industry. Over the past year, Bath & Body Works has experienced a notable decrease in its stock price, with a performance drop of 45.01%, contrasting sharply with the S&P 500's gain of 16.64%.
The company's market capitalization stands at USD 6,299 million, and it currently has a price-to-earnings (P/E) ratio of 7.00. However, Bath & Body Works is facing challenges reflected in its financial metrics, including a negative return on equity and a concerning debt-to-equity ratio of -2.40. The company has also reported a decline in net sales at an annual rate of -8.28% over the last five years.

With a dividend yield of 3.49%, Bath & Body Works continues to navigate a difficult market landscape, characterized by consistent underperformance against the S&P 500 over the past three years. The stock's recent low underscores the ongoing challenges the company faces in achieving long-term growth and stability.